Focus Taiwan App
Download

CRISPR/Cas9 gene-editing will be used in human embryos: Doudna

09/24/2016 08:30 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

U.S. geneticist Jennifer Doudna, one of this year's three recipients of the Tang Prize in biopharmaceutical science, said Saturday that public education on the gene-editing technology she is being honored for is needed, especially when considering its use in human embryos.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.17